Henry Shion

Henry Shion serves as the Director of Analytical Development and Characterization at Leap Therapeutics since July 2022. Prior to this role, Henry Shion built an extensive career at Waters Corporation from September 1998 to July 2022, where responsibilities included Principal Scientist, Senior Scientist, Senior Application Specialist, and Product Specialist II. Earlier, Henry Shion worked as a Postdoctoral Research Fellow at the University of Illinois Chicago under Dr. Richard van Breemen, where a significant contribution involved developing a method for the quantitative analysis of nucleosides related to DNA oxidation using LC-MS/MS. Henry Shion holds a Doctor of Philosophy (PhD) degree in Analytical Chemistry from Drexel University.